Accelerated Path to Approval
Our integrated development and data-driven approach support an efficient regulatory pathway, helping bring your product to approval faster.
Learn more
MedPharm partners with pharmaceutical and biotech companies to develop, test, and manufacture topical and transepithelial products — reducing risk and accelerating the path to patients.
Expertise Across Multiple Routes of Delivery
Strategic formulation development for topical and transepithelial drug products, focused on optimizing delivery, stability, and patient performance.
Comprehensive analytical and testing services to support development, quality, and regulatory requirements, delivering reliable data to guide critical decisions.
Scalable GMP manufacturing for semi-solid and liquid drug products, supporting clinical supply through commercial production with quality and consistency.
Process development and scale-up to translate formulations from lab to manufacturing, ensuring robust, reproducible performance at commercial scale.
IVRT, IVPT, and Research Biology models to evaluate drug release, permeation, and pharmacological activity across development.
Clinical trial material manufacturing and supply to support early- and late-stage studies, ensuring quality, consistency, and reliable delivery.
Analytical and testing services to support early development, method development, and characterization, delivering reliable data to guide formulation decisions.
Formulation development for topical and transdermal products, optimizing delivery, stability, and performance from the earliest stages.
IVRT, IVPT, and Research Biology models to evaluate drug release, permeation, and pharmacological activity, supporting formulation development and regulatory strategy.
Process development and scale-up to translate formulations from lab to manufacturing, ensuring robust and reproducible performance.
Seamless technology transfer to manufacturing, ensuring process consistency, knowledge continuity, and efficient scale-up.
Validation studies to confirm process performance, product quality, and readiness for regulatory submission and commercialization.
Scalable GMP manufacturing for semi-solid and liquid drug products, supporting consistent, high-quality commercial supply.
ICH-compliant stability studies to support product shelf-life, regulatory submissions, and ongoing commercial supply.
Packaging and serialization solutions to support product integrity, compliance, and global distribution requirements.
Targeted dermal and transdermal delivery to the skin for local and systemic action (e.g., inflammation, infection, or barrier repair). Expertise in optimizing formulation penetration, retention, and patient experience for creams, gels, and patches.
Learn More
Niche delivery routes for difficult-to-penetrate tissues. MedPharm offers proprietary nail permeation models and specialized testing platforms for scalp/follicular delivery and keratinized tissue applications.
Learn More
Sterile or preservative-containing formulations for ocular delivery. Expertise in particle suspension stability, viscosity control, and packaging compatibility for drops, gels, and sprays.
Learn More
Specialized formulations for treating outer and middle ear conditions. Focus on retention, comfort, and antimicrobial performance in dose forms like drops, foams, and gels. Custom models support precise...
Learn More
Fast-acting, non-invasive delivery directly to the lungs through nasal routes, enabling rapid onset, reduced systemic side effects, and effective treatment of respiratory and systemic conditions.
Learn More
Advancing Formulations for Localized and Systemic GI Therapies At MedPharm, we specialize in the development of innovative drug products targeting the gastrointestinal (GI) tract, with expertise spannin...
Learn More
Developing topical formulations, patches, and applications for women’s health, including delivery for vaginal, cervical, vulvar, and perineal tissues.
Learn More
Formulations for direct absorption through sensitive and highly vascularized mucosa. Includes compatibility testing, retention optimization, and patient-centric dose forms like gels, foams, and suppositories.
Learn More
Our integrated development and data-driven approach support an efficient regulatory pathway, helping bring your product to approval faster.
Learn more
Successfully inspected by the FDA with no Form 483 observations and a No Action Indicated (NAI) classification, demonstrating the strength of our quality systems and readiness for commercial manufacturing.
Learn more
Specialized analytical and in vitro performance testing, including IVRT and IVPT, generate data that supports confident development decisions and regulatory submissions.
Learn more
From pilot batches to GMP manufacturing, we scale topical and transdermal formulations efficiently across our UK and US facilities.
Learn more
Over 25 years of specialized experience developing complex topical and transdermal drug products across multiple routes of delivery.
Learn more